Essex Woodlands Health Ventures VIII L.L.C. 13D/13G Filings for Revance Therapeutics, Inc. (RVNC)

Essex Woodlands Health Ventures VIII L.L.C. 13D and 13G filings for Revance Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-02-10
06:01 am
Sale		 2021-01-20 13G Revance Therapeutics, Inc.
RVNC		 Essex Woodlands Health Ventures VIII L.L.C. 457,085
0.007%		 -2,884,962decrease
(-86.32%)		 Filing